UFC drug policy is a good start, but doesn’t go far enough

The UFC held a press conference this week to discuss their new Athlete Marketing and Development program. The press conference announced partnerships with Fusionetics and EXOS, revealed plans for a rehab facility called the UFC Lab, and officially introduced Jeff Novitzky as the head of the program. The centerpiece of the presser, however, was the unveiling of the UFC drug policy in conjunction with the United States Anti-Doping Agency.

The policy is robust. Performance-enhancing drugs will be tested both in and out of competition. The first failed test is subject to a two-year suspension and the potential for four years for “aggravated circumstances.” Penalties double for second and third…